Crohn's disease (CD) and ulcerative colitis (UC) are subforms of inflammatory bowel diseases (IBD). Genetic and environmental factors influencing the onset and course of the diseases have been recently identified. This study uses a twostep approach to detect genes involved in the pathogenesis of IBD by microarray analysis and real-time PCR (RT-PCR). In a first step, microarray expression screening was used to obtain tumour necrosis factor-a (TNF-a) induction profiles of two human cell lines to represent the tissue cell types involved in IBD. In a second step, a subset of differentially expressed genes was examined by real-time PCR in intestinal biopsy samples of normal controls (NC) compared with UC and CD patients, as well as to a cohort of patients suffering from intestinal diseases other than IBD. Data were obtained from 88 CD, 88 UC, 53 non-IBD patients (inflammatory control), DC and 45 NC individuals. The experimental design enabled the identification of disease-specific expressed genes. DnaJ (Hsp40) homologue, subfamily B, member 5 (DNAJB5) was downregulated in intestinal biopsy samples of the UC cohort compared with NC. A difference in JUNB expression levels was observed by comparing biopsy samples from inflamed and non-inflamed areas of UC patients. Transcript expression differences between IBD and control cohorts were found by examining histamine N-methyltransferase (HNMT), interleukin-1A (IL-1A) and proplatelet basic protein (PPBP) expression. The experimental procedure represents an approach to identify disease-relevant genes, which is applicable to any disease where appropriate model systems are available.
Introduction
The pathophysiology of Crohn's disease (CD) and ulcerative colitis (UC) has been intensively investigated in the last decades. Epidemiological and hereditary studies have demonstrated that genetic as well as environmental factors influence susceptibility to inflammatory bowel diseases (IBD) and disease course. 1, 2 For example, significant linkage of a CD susceptibility locus to markers on chromosome 16, designated IBD1, was reported in 1996. Fine mapping of this region identified the first CD susceptibility gene, CARD15.
3 Furthermore, two distinct haplotypes of DLG5 (involved in the maintenance of epithelial integrity) have been previously reported to be associated with IBD, in particular with CD. 4 Single nucleotide polymorphisms altering the transcription of OCTN1/2 and the molecular function of the encoded proteins, which are involved in organic cation transport, have been reported to increase susceptibility to CD. 5 Missense mutations of the MDR1 gene are associated with standard therapy refractory CD and UC. 6, 7 Several additional susceptibility loci have been reported for IBD on different chromosomes. [8] [9] [10] The high number of susceptibility loci in combination with nongenetic factors, such as nutrition and smoking habits, 1, 11 illustrates the complex pathophysiology of CD and UC.
Proper function of the intestinal immune system requires a carefully regulated balance of proinflammatory and anti-inflammatory processes, which interact to promote a normal host defence of the mucosal barrier. Alterations of this balance may result in bacterial invasion and disturbance of the barrier function of the mucosa. 12 IBD is characterized by a predominance of proinflammatory molecules in the intestinal mucosa. 13, 14 Among the immune modulating cytokines, tumor necrosis factor-a (TNF-a) plays a central role in the pathogenesis of IBD. 15, 16 On the basis of these findings, anti-TNF-a antibodies have been developed and successfully introduced into therapy of IBD. [17] [18] [19] [20] [21] The demonstrated importance of TNF-a in the pathology of IBD makes it an excellent starting point for further investigations into the downstream processes mediated by this important cytokine. To this end, we first analysed the global gene expression changes in TNF-a-stimulated human model cell lines (intestinal epithelial cell line CaCo-2, monocytic cell line THP-1) using highdensity microarrays. In a second in vivo step, the expression of these genes was assessed in intestinal biopsy samples of CD patients, UC patients, patients suffering from intestinal diseases other than IBD (DC) and normal controls (NC) to determine the pathophysiological relevance of the observed expression pattern changes in vivo.
Results
Microarray expression screening of model cell lines stimulated with TNF-a The high technical reliability of the microarray experiments resulted in an average correlation coefficient between the spotted duplicates of r 2 ¼ 0.99. Overall, 1594 transcripts (4.7% of all clones spotted onto array) were identified as being differentially regulated by comparing unstimulated and stimulated THP-1 cells. In summary, 1062 transcripts were statistically significantly upregulated (67%, Po0.025) and 532 transcripts (33%, Po0.025) were downregulated. The magnitude of differential regulation ranged from 8.7-fold upregulation to 7.9-fold downregulation. In TNF-a stimulated CaCo-2 cells, 994 (2.9%) of the 33 792 transcripts were determined to be differentially regulated: 832 (83.7%) transcripts were upregulated, while 162 (16.3%) were downregulated when comparing stimulated and unstimulated cells. Fold changes ranged from 9.2-fold upregulation to 8.7-fold downregulation. The microarray result data files have been deposited to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/ projects/geo) and can be found under the accession numbers GSE10106 and GSE 10108.
Eleven of the differentially expressed transcripts were subjected to further real-time PCR (RT-PCR) analysis in the intestinal biopsy samples of IBD patients and control populations (Table 1) . Microarray expression screening results of the transcripts chosen for further RT-PCR analyses are presented in Table 2 . Differential expression is given as ratio of gene expression after and before stimulation (a ratio 41.0 indicates upregulation; ratio o1.0 downregulation). Seven genes were chosen for RT-PCR verification due to their direct relevance to IBD, either through their position in IBD linkage regions (catenin (cadherin-associated protein) a1 (CTNNA1), jun B proto-oncogene (JUNB), transcription factor 7 (TCF7) 22, 23 ) or involvement in inflammation processes (Interleukin-(IL) 1A, IL-1B, IL-8 and histamine N-methyltransferase (HNMT)). The remaining genes were chosen as they were not directly involved in inflammation mediation. These genes are nevertheless interesting because they may represent processes underlying the immune deregulation associated with IBD. Table 3 provides additional information concerning chromosomal location and known or proposed biological function of gene products of the 11 genes selected for further RT-PCR analysis.
Real-time PCR quantification of transcripts in IBD patients
The correlation coefficients of the target gene standard curve were higher than r 2 ¼ 0.90 in RT-PCR experiments (endogenous control r 2 X0.97). Table 4 and Figure 1 summarize the RT-PCR results of CD, UC, disease control (DC) and NC cohort comparisons.
CTNNA1 transcript expression levels were found to differ significantly comparing the CD, UC and DC to the NC cohort. Expression levels in all three cohorts of diseased individuals were lower than in the NC cohort. These differences were observed in inflamed and not inflamed tissue. Comparison of both IBD cohorts against each other revealed no significant difference. The CTNNA1 gene is closely related to the IBD linkage locus IBD5 on chromosome 5q31. Statistically significant DNAJB5 expression differences were only found comparing UC and NC or DC cohorts. Expression levels in UC were lower than in NC or DC.
Filamin A (FLNA) expression pattern were found to be similar to those of CTNNA1. CD, UC and DC cohorts exhibited lower FLNA expression levels than the NC cohort. These differences were not dependent on the inflammation status of the examined mucosa biopsy tissue.
The RT-PCR expression analysis detected lower HNMT expression levels in the UC than in the NC cohort. While inflamed mucosa areas showed lower HNMT levels than not inflamed areas, there was no difference between inflamed and not inflamed areas of DC cohort patients. However, expression levels in CD were higher than in UC.
IL-1A expression levels in the UC cohort were significantly higher than in NC, while no differences were found in comparison of CD and DC with the control cohort. Inflamed mucosa areas of IBD patients exhibited higher IL-1A expression levels than not inflamed areas. Comparison of UC and DC cohorts resulted also in a significant higher IL-1A expression level in UC. No significant transcript expression level differences were detected between CD, UC, DC and NC cohorts. Stratification according to the inflammation status showed higher expression levels in inflamed than in not inflamed tissue of CD, UC and DC cohorts. Similar findings were made in IL-8 expression analysis.
Mucosal biopsies of CD, UC and DC patients showed significant higher IL-1B gene expression levels than those of not inflamed areas of the same cohort.
JUNB transcript expression levels in inflamed UC mucosa were significantly higher than in not inflamed. No further statistically significant JUNB expression differences between cohorts or subgroups were found. The chromosomal location of JUNB is within the susceptibility locus IBD6 on chromosome 19p13.
Proplatelet basic protein (PPBP) and IL-8 transcript expression analysis resulted in comparable findings. Additionally, expression levels in the UC cohort were lower than in the DC cohort. The CD cohort exhibited higher transcript expression levels than the DC cohort.
Protein kinase D3, PRKD3 (PRKCN) expression profiles were very similar to those observed in FLNA expression screening experiments. A significant lower transcript expression than in NC became apparent in both IBD cohorts as well as in the DC cohort.
The DC cohort exhibited statistically significant higher TCF7 levels than the control cohort. All further cohort comparisons did not result in significant findings. The IBD susceptibility locus IBD5 includes the TCF7 gene locus at 5q31.1. 
Discussion
Owing to the complexity of both forms of IBD and the outstanding pathophysiological role of TNF-a, investigation of relevant gene products has been primarily focused on TNF-a-related inflammation and cellular response. The pathogenesis of inflammation in IBD is modulated by the involvement and activation of intestinal epithelial cells, [24] [25] [26] [27] which may be represented by cell line models. Past studies have demonstrated that findings made in CaCo-2 cells are largely reproducible in primary human intestinal epithelial cells. 28, 29 CaCo-2 cell monolayers are an established model to imitate the intestinal mucosa in drug development. 30 THP-1 cells are a common model for human monocytes. 31, 32 To differentiate IBD-specific changes of gene expression from unspecific inflammation-related effects, IBD cohorts were compared with NCs, and additionally to a cohort of patients suffering from intestinal inflammatory diseases such as ischaemic and infectious colitis.
All of the transcripts examined with RT-PCR exhibited differential expression when comparing cohorts or subcohorts of diseased patients to the control cohorts. Microarray gene expression results of three (CTNNA1, HNMT and PRKCN) of the eleven transcripts could not be verified. While microarray experiments showed a significant upregulation of gene expression in response to TNF-a stimulation, comparison of gene expression levels in sample material from CD, UC and DC cohorts with the NC cohort resulted in a significant downregulation. The cell line model system did not obviously reproduce the observed in vivo transcriptional control of these genes. In the following discussion, genes are grouped into functional categories (inflammation and immune response, structure, cell proliferation and signalling) according to known or predicted physiological gene function.
Inflammation/immune response Interleukin-1 gene cluster (chromosome 2q14). IL-1A and IL-1B are part of the IL-1 superfamily and located in a gene cluster on chromosome 2q14. An involvement of members of the IL-1 superfamily in the development of intestinal inflammation as observed in IBD has been previously reported. 33 An imbalance of the IL-1 system is associated with intestinal inflammation in IBD. [34] [35] [36] IL-1A, one of the proinflammatory cytokines, is produced by activated macrophages and stimulates lymphocyte proliferation and differentiation, regulates the release of inflammation mediators and is involved in the cellular inflammatory response. 28, 34, 35, [37] [38] [39] [40] [41] IL-1A gene expression and release by macrophages/monocytes and THP-1 cells has been demonstrated in several studies. [42] [43] [44] [45] [46] In complete accordance with these findings, we observed a TNF-a dependent upregulation of IL-1A in THP-1, but not in CaCo-2 microarray experiments. Our findings indicate an IBD-specific gene expression regulation for IL-1A. The cell line experiments suggest that intestinal macrophages/monocytes are the main source of intestinal IL-1A expression, as differential regulation was detected in THP-1 but not CaCo-2 cells.
IL-1B is mainly produced by macrophages but also in intestinal epithelial cells. 38 It is an important mediator of inflammation and involved in many cellular processes (proliferation, differentiation and apoptosis). 38, 47 Polymorphisms of the IL-1B gene have been reported to influence course and severity of IBD. 48 The increased expression in inflamed mucosa areas did not seem to be IBD-specific but more a general mechanism of intestinal inflammation. The gene expression differences between active and inactive intestinal inflammation are in accordance with reported IL-1B regulation mechanisms. 34, 35, 49 CXC chemokine cluster on chromosome 4q13. Two of the transcripts tested, namely IL-8 and PPBP are localized to a CXC chemokine locus on chromosome 4q13. 50 IL-8, mainly produced by macrophages, was tested by RT-PCR after assessing differential expression in microarray experiments. Expression levels in inflamed tissue were generally higher than in non-inflamed as recently reported. 51, 52 A correlation between inflammatory activity and IL-8 expression has been described. 53 The PPBP gene encodes a protein of the CXC chemokine family and was significantly upregulated in both IBD cohorts when compared with NC. PPBP is involved in neutrophil adhesion and transendothelial migration, regulating neutrophil activation and is a potent chemoattractant. 55 PPBP gene products were determined to be bactericidal in different bacterial species. Expression in monocytes 56 indicates an additional function of PPBP gene products in innate microbial defence and suggests a potential role in the intestinal mucosa. The upregulation of gene expression found in TNF-a stimulated THP-1 cells in contrast to CaCo-2 cells indicates that intestinal monocytes/macrophages are a likely source of PPBP expression in the intestinal mucosa. The dysregulation of PPBP expression may be associated with an impaired immune defence in IBD. The results indicate that members of the CXC chemokine cluster on chromosome 4q13 could play an important role in the pathogenesis of IBD as shown in the IL-1 gene cluster. The interplay of the different co-localized chemokines should be subjected to further investigation.
Structure
The E-cadherin/catenin complex has been implicated in processes of cell-cell adhesion and signal transduction. The dysfunction in intestinal cell-cell adhesion and the intestinal barrier is one of the characterizing features of IBD. A marked downregulation of different junctional proteins, including the E-cadherin/catenin complex, was observed in actively inflamed tissue. [57] [58] [59] Reduced expression of CTNNA1 (a member of the cadherin/ catenin complex) seems to be a common feature of UC and CD, and could represent a general tissue reaction to inflammation as CTNNA1 is also downregulated in DC compared with NC.
FLNA is essential for stabilization of actin networks and interacts with integrins, transmembrane receptor complexes and second messengers. 60, 61 Decreased expression in inflamed CD, UC and DC compared with NC ( Figure 1 ) might be associated with an altered mucosal barrier function.
Cell proliferation and signalling JUNB is a member of the Jun gene family, which are components of the activating protein-1 (AP-1) transcription factor complexes that control cell proliferation, differentiation and transformation. 62 The only significant differential gene expression detected in JUNB RT-PCR experiments was observed when comparing expression levels in UC biopsies of inflamed and non-inflamed areas, suggesting UC specificity. The differential expression of the proto-oncogene JUNB may be related to the increased incidence rates of colorectal cancer in UC with extensive colitis. 63 PRKCN, an ubiquitously expressed member of the protein kinase C family, is involved in cell differentiation regulation and proliferation of various different cell types. 64 Its role in cell activation, differentiation, proliferation and B-cell receptor signalling may contribute to the epithelial destruction characterizing IBD, or to an impaired activation of the intestinal defence mechanisms. RT-PCR results suggest a general involvement in intestinal inflammation.
Histamine is one of the key mediators of allergic diseases and inflammation. An inflammation-related increase of histamine secretion in IBD has been demonstrated in two studies. 65, 66 An association between UC and a polymorphism of the diamine oxidase gene, a histamine metabolizing enzyme, has been reported by Garcia-Martin et al. 67 HNMT catalyses the N-methylation of histamine in the degradation process. The downregulation of HNMT in biopsies of inflamed mucosa from IBD patients could lead to overactivation of inflammation signalling as a result of the affected histamine degradation.
DNAJB5 is a recently characterized member of the heat shock protein (Hsp) 40 family. This protein family is involved in cellular reactions to different kinds of stress.
68,69 UC-specific differential gene expression observed in this study indicates a potential role in the pathogenesis of UC. An association between anti-Hsp40 autoantibodies and UC was reported by Sato et al. 70 A recently published study found an Hsp40 and Hsp70-dependent resistance to dextran sulphate sodium colitis in macrophage migration inhibitory factor null mice. 71 Interestingly, TCF7 was the only transcript significantly differentially expressed in DC but not in the UC or CD cohorts. TCF7 is reported to be preferentially expressed in T cells and involved in cell differentiation and gene expression. 72, 73 Altogether, this study identified IBD-specific (DNAJB5 (UC-specific), HNMT, IL-1A, JUNB (UC inflammation specific), PPBP) as well as unspecific inflammationrelated gene expression patterns (CTNNA1, FLNA, IL-1B, PRKCN) and highlights valid candidates for further investigation. As the successful application of anti-TNF treatments has proven, disease specificity is not a stringent requirement in the development of powerful therapies for IBD. The identification of potential therapeutic targets downstream of the TNF-a signalling cascade, such as those identified in this study, may enable the development of therapeutic agents with a higher specificity for pathogenetic relevant targets.
In conclusion, this experimental approach offers a way of transferring in vitro findings to the in vivo environment and can be adopted for candidate gene identification in numerous diseases.
Materials and methods

Cell culture
The two human cell lines, THP-1 (acute monocytic leukaemia; ATCC, Manassas, VA, USA) and CaCo-2 (colon adenocarcinoma; DSMZ, Braunschweig, Germany) were used in this study. THP-1 cells were cultured in RPMI 1640 containing 2 mM L-glutamine and 10% foetal bovine serum supplemented 50 mM 2-mercaptoethanol, 100 U ml À1 penicillin and 100 mg ml À1 streptomycin. Subculturing was performed by splitting cells when the concentration exceeded 1 Â 10 6 cells per ml. Cells were stimulated in cell culture dishes in 10 ml of medium and a cell concentration of 0.5 Â 10 6 cells per ml. CaCo-2 cells were cultured in Dulbecco's minimal essential medium containing 20% foetal bovine serum, 100 U ml À1 penicillin and 100 ng ml À1 streptomycin. Both cell lines were stimulated for 60 min using rhTNF-a (R&D Systems, Minneapolis, MN, USA) at a final concentration of 5 ng ml
À1
. The TNF-a dose for cell stimulation and the time point of stimulation were optimized by preparatory cell line stimulation experiments (data not shown). A number of technical replicates was performed for each cell line and stimulation: unstimulated CaCo-2 and THP-1 cells experiments were replicated n ¼ 8 and 7 times, respectively; CaCo-2 and THP-1 TNF-a stimulation experiments were repeated n ¼ 10 and 8 times, respectively.
RNA isolation, sample preparation and microarray hybridization The high-density cDNA microarrays used in this study were produced at the Max Planck Institute for Molecular Genetics, Berlin, Germany. [74] [75] [76] RNA isolation, cDNA preparation and hybridization were performed as previously described by Mah et al. 77 and Costello et al.
78
A description of the array characteristics and the result files have been deposited to NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/projects/geo, GPL284). A description of RNA isolation, sample preparation, radioactive labelling and array hybridization procedures can be found under accession numbers GSE10106 and GSE10108.
Microarray data analysis
The datasets derived from microarray image analysis using AIDA software (Raytest, Straubenhardt, Germany) were transferred into a relational database. As the ranked expression data were found to be distributed according to Zipfs law, 79 normalization procedures were performed as previously described by Lu et al. 80 Signal intensities lower than background intensity plus two times the s.d. were excluded from further procedures. All transcripts were applied in duplicate to the microarrays. The average correlation coefficient was r 2 ¼ 0.99. Transcripts showing hybridization signal intensity differences of duplicates higher than 20% were also excluded from further analysis.
Significance of differences between the experimental groups was assessed by Mann-Whitney U-test. The interassay variability was calculated for each of the 33 792 replicate signals. On the basis of this result, a significant technical threshold for comparative profiling between the samples of normal and test condition was set to P-value p0.025 and a fold change X1. Table 1 . No subgroup was smaller than 10 individuals in statistical analysis. In this study, only patients showing CDAI4150 or CAI46 were included in the CD or UC cohorts, respectively. All of these patients were free of all IBD medication other than low dose 5-ASA for at least 6 weeks before sampling date. Histopathological examination and disease activity evaluation were performed by pathologists. The informed consent to give research biopsies of all patients was given 424 h before endoscopy. The study protocol was been reviewed and approved by the ethical committee of the University Hospital Schleswig-Holstein.
Sample preparation for real-time PCR experiment Total RNA from patient biopsies was reverse transcribed using MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. A standard curve was generated by serial dilution of a standard cDNA sample. cDNA obtained from patients and standard samples were pipetted in quadruplicate to 384-well PCR plates for quantification of target and housekeeper genes. Probes and primers were either designed with non-redundant sequences using Primer Express V2.0 Assay-on-demand gene assays are provided with context sequence surrounding the assay location.
From model cell line to in vivo gene expression HA Schulze et al (Applied Biosystems), or ordered from Applied Biosystems as assays-on-demand or assay-by-design gene expression assays (Table 5 ). All experiments were performed with TaqMan Universal PCR Mastermix (Applied Biosystems). 4.5 ml master mix, 0.2 ml fluorescently labelled probe (10 mM) and 0.15 ml forward and reverse primers (20 mM) were added to each well plate. The final reaction volume was set to 10 ml. The PCR conditions were: 2 min at 50 1C, 10 min at 95 1C followed by 40 cycles of 15 s at 95 1C and 1 min at 60 1C. Reactions were carried out on the ABI PRISM Sequence 7700 Detection System (Applied Biosystems) and relative transcript levels were determined using b-actin as endogenous control gene.
Statistical analysis of real-time PCR results
Biopsy sample plates were analysed using the standard curve method. 81 Statistical differences between the cohorts were estimated for each family of hypotheses (H 0 : m 1 ¼ m 2 ) by the non-parametric Kruskal-Wallis test (Po0.05). The non-parametric Mann-Whitney U-test was used to assess statistical significance in the comparison with cohorts. Significance levels were adjusted according to the Bonferroni correction method.
